Interspecies differences in metabolism of arsenic by cultured primary hepatocytes

被引:55
作者
Drobna, Zuzana [1 ]
Walton, Felecia S. [1 ]
Harmon, Anne W. [1 ]
Thomas, David J. [2 ]
Styblo, Miroslav [1 ,3 ]
机构
[1] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA
[2] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Integrated Syst Toxicol Div,Pharmacokinet Branch, Res Triangle Pk, NC 27711 USA
[3] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC 27599 USA
关键词
Arsenic; Primary hepatocytes; Metabolism; As3mt; Mammalian species; OXIDATION-STATE METHYLTRANSFERASE; ENZYMATIC METHYLATION; CYSTEINE RESIDUES; IN-VITRO; IDENTIFICATION; POLYMORPHISMS; REDUCTASE; MARMOSET; MONKEYS; CELLS;
D O I
10.1016/j.taap.2010.01.015
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Biomethylation is the major pathway for the metabolism of inorganic arsenic (iAs) in many mammalian species, including the human. However, significant interspecies differences have been reported in the rate of in vivo metabolism of iAs and in yields of iAs metabolites found in urine. Liver is considered the primary site for the methylation of iAs and arsenic (+3 oxidation state) methyltransferase (As3mt) is the key enzyme in this pathway. Thus, the As3mt-catalyzed methylation of iAs in the liver determines in part the rate and the pattern of iAs metabolism in various species. We examined kinetics and concentration-response patterns for iAs methylation by cultured primary hepatocytes derived from human, rat, mice, dog, rabbit, and rhesus monkey. Hepatocytes were exposed to [As-73]arsenite (iAs(III); 0.3, 0.9, 3.0, 9.0 or 30 nmol As/mg protein) for 24 h and radiolabeled metabolites were analyzed in cells and culture media. Hepatocytes from all six species methylated iAs(III) to methylarsenic (MAs) and dimethylarsenic (DMAs). Notably, dog, rat and monkey hepatocytes were considerably more efficient methylators of iAs(III) than mouse, rabbit or human hepatocytes. The low efficiency of mouse, rabbit and human hepatocytes to methylate iAs(III) was associated with inhibition of DMAs production by moderate concentrations of iAs(III) and with retention of iAs and MAs in cells. No significant correlations were found between the rate of iAs methylation and the thioredoxin reductase activity or glutathione concentration, two factors that modulate the activity of recombinant As3mt. No associations between the rates of iAs methylation and As3mt protein structures were found for the six species examined. Immunoblot analyses indicate that the superior arsenic methylation capacities of dog, rat and monkey hepatocytes examined in this study may be associated with a higher As3mt expression. However, factors other than As3mt expression may also contribute to the interspecies differences in the hepatocyte capacity to methylate iAs. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:47 / 56
页数:10
相关论文
共 32 条
  • [1] Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase
    Drobná, Z
    Waters, SB
    Devesa, V
    Harmon, AW
    Thomas, DJ
    Styblo, M
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2005, 207 (02) : 147 - 159
  • [2] Interindividual variation in the metabolism of arsenic in cultured primary human hepatocytes
    Drobná, Z
    Waters, SB
    Walton, FS
    LeCluyse, EL
    Thomas, DJ
    Styblo, M
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 201 (02) : 166 - 177
  • [3] shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells
    Drobna, Zuzana
    Xing, Weibing
    Thomas, David J.
    Styblo, Miroslav
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2006, 19 (07) : 894 - 898
  • [4] Metabolism of arsenic in human liver: the role of membrane transporters
    Drobna, Zuzana
    Walton, Felecia S.
    Paul, David S.
    Xing, Weibing
    Thomas, David J.
    Styblo, Miroslav
    [J]. ARCHIVES OF TOXICOLOGY, 2010, 84 (01) : 3 - 16
  • [5] Disruption of the Arsenic (+3 Oxidation State) Methyltransferase Gene in the Mouse Alters the Phenotype for Methylation of Arsenic and Affects Distribution and Retention of Orally Administered Arsenate
    Drobna, Zuzana
    Naranmandura, Hua
    Kubachka, Kevin M.
    Edwards, Brenda C.
    Herbin-Davis, Karen
    Styblo, Miroslav
    Chris Le, X.
    Creed, John T.
    Maeda, Noboyu
    Hughes, Michael F.
    Thomas, David J.
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2009, 22 (10) : 1713 - 1720
  • [6] High-throughput identification of catalytic redox-active cysteine residues
    Fomenko, Dmitri E.
    Xing, Weibing
    Adair, Blakely M.
    Thomas, David J.
    Gladyshev, Vadim N.
    [J]. SCIENCE, 2007, 315 (5810) : 387 - 389
  • [7] Enzymatic methylation of arsenic compounds V. Arsenite methyltransferase activity in tissues of mice
    Healy, SM
    Casarez, EA
    Ayala-Fierro, F
    Aposhian, HV
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1998, 148 (01) : 65 - 70
  • [8] Enzymatic methylation of arsenic compounds .4. In vitro and in vivo deficiency of the methylation of arsenite and monomethylarsonic acid in the guinea pig
    Healy, SM
    Zakharyan, RA
    Aposhian, HV
    [J]. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 1997, 386 (03) : 229 - 239
  • [9] High arsenic metabolic efficiency in AS3MT287Thr allele carriers
    Hernandez, Alba
    Xamena, Noel
    Sekaran, Chandra
    Tokunaga, Hiroshi
    Sampayo-Reyes, Adriana
    Quinteros, Domingo
    Creus, Amadeu
    Marcos, Ricardo
    [J]. PHARMACOGENETICS AND GENOMICS, 2008, 18 (04) : 349 - 355
  • [10] WIDESPREAD OCCURRENCE OF 3 SEQUENCE MOTIFS IN DIVERSE S-ADENOSYLMETHIONINE-DEPENDENT METHYLTRANSFERASES SUGGESTS A COMMON STRUCTURE FOR THESE ENZYMES
    KAGAN, RM
    CLARKE, S
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1994, 310 (02) : 417 - 427